| | |
Boys
|
Girls
|
|---|
|
Model
|
Genotypes
|
aORa (95% CI)
|
P value
|
aORa (95% CI)
|
P value
|
|---|
| |
AGT
| | | | |
|
Co-dominant
|
MM
|
1.00
| |
1.00
| |
|
MT
|
1.20 (0.70–2.03)
|
0.509
|
1.03 (0.58–1.84)
|
0.926
|
|
TT
|
0.72 (0.39–1.33)
|
0.296
|
0.72 (0.34–1.54)
|
0.400
|
|
Dominant
|
MM
|
1.00
| |
1.00
| |
|
MT + TT
|
0.99 (0.61–1.64)
|
0.994
|
0.94 (0.54–1.63)
|
0.817
|
|
Recessive
|
MM + MT
|
1.00
| |
1.00
| |
|
TT
|
0.65 (0.39–1.07)
|
0.091
|
0.71 (0.37–1.36)
|
0.301
|
|
Additive
| |
0.85 (0.63–1.15)
|
0.304
|
0.87 (0.60–1.25)
|
0.448
|
| |
AGTR1
| | | | |
|
Co-dominant
|
AA
|
1.00
| |
1.00
| |
|
AC
|
0.84 (0.53–1.33)
|
0.451
|
0.99 (0.59–1.68)
|
0.986
|
|
CC
|
0.66 (0.29–1.48)
|
0.309
|
1.21 (0.44–3.33)
|
0.771
|
|
Dominant
|
AA
|
1.00
| |
1.00
| |
|
AC + CC
|
0.80 (0.52–1.24)
|
0.323
|
1.02 (0.62–1.69)
|
0.929
|
|
Recessive
|
AA + AC
|
1.00
| |
1.00
| |
|
CC
|
0.71 (0.32–1.56)
|
0.391
|
1.21 (0.45–3.25)
|
0.700
|
|
Additive
| |
0.82 (0.58–1.15)
|
0.256
|
1.05 (0.70–1.57)
|
0.821
|
| |
ACE
| | | | |
|
Co-dominant
|
II
|
1.00
| |
1.00
| |
|
ID
|
2.05 (1.19–3.53)
|
0.010
|
0.92 (0.51–1.67)
|
0.793
|
|
DD
|
1.43 (0.76–2.69)
|
0.226
|
0.89 (0.44–1.82)
|
0.749
|
|
Dominant
|
II
|
1.00
| |
1.00
| |
|
ID + DD
|
1.82 (1.09–3.04)
|
0.022
|
0.91 (0.52–1.60)
|
0.752
|
|
Recessive
|
II + ID
|
1.00
| |
1.00
| |
|
DD
|
0.89 (0.53–1.48)
|
0.646
|
0.94 (0.52–1.70)
|
0.834
|
|
Additive
| |
1.20 (0.88–1.63)
|
0.253
|
0.94 (0.66–1.35)
|
0.745
|
-
Abbreviations: AGT angiotensinogen, AGTR1 angiotensin II receptor 1, ACE angiotensin-converting enzyme, aOR adjusted odds ratio, CI confidence intervals
-
aadjusted for the body mass index and waist circumference
